Proposed Data Collection Submitted for Public Comment and Recommendations, 4890-4891 [2022-01885]
Download as PDF
<![CDATA[
4890
Federal Register / Vol. 87, No. 20 / Monday, January 31, 2022 / Notices
acip/meetings/ no later than 11:59 p.m.,
EST, February 21, 2022, according to the
instructions provided.
If the number of persons requesting to
speak is greater than can be reasonably
accommodated during the scheduled
time, CDC will conduct a lottery to
determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
by February 22, 2022. To accommodate
the significant interest in participation
in the oral public comment session of
ACIP meetings, each speaker will be
limited to 3 minutes, and each speaker
may only speak once per meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–01820 Filed 1–28–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–22CB; Docket No. CDC–2022–
0011]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
Agencies the opportunity to comment
on a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Assessment for the Get Ahead of
Sepsis (GAOS) Consumer Campaign.
This assessment collects on-line survey
data from target consumer groups and
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:38 Jan 28, 2022
Jkt 256001
healthcare professionals (HCP) before
and after the campaign.
DATES: CDC must receive written
comments on or before April 1, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0011 by either of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal Agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Assessment for the Get Ahead of
Sepsis (GAOS) Consumer Campaign—
New—National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Sepsis is a life threating emergency,
and it is the body’s overactive and toxic
response to an infection. Each year 1.7
million adults in the United States
develop sepsis, with 270,000 fatalities.
Sepsis is the leading cause of death in
hospitals and one out of three hospital
fatalities are due to sepsis infection.
Sepsis management in U.S. hospitals is
the highest when compared to inpatient
cost for all other medical conditions.
Annual costs are estimated to be over
$62 billion.
In media and public health
campaigns, antimicrobial resistance and
sepsis are rarely presented together
which does not make their linkage
apparent. It has been concluded that
sepsis and antimicrobial stewardship
should not be discussed in isolation.
Surprisingly, 24 percent of adults in the
U.S. have never heard of sepsis, so this
presents a unique opportunity for future
messaging campaigns.
The goals of the GAOS educational
campaign are to prevent and reduce
infections that lead to sepsis and to
optimize healthcare quality and patient
safety by raising awareness, knowledge,
and motivating behavior change related
to sepsis prevention, early recognition,
and appropriate treatment among
consumer target audiences. A panel
survey will be utilized to recruit
participants. Surveys will be distributed
to consumer target groups and HCPs
both before and after the media
campaign and partner outreach.
Consumer audiences include:
(1) Cancer patients and their
caregivers (English speaking),
(2) Patients who survived severe
COVID–19 or sepsis and their caregivers
(English speaking),
E:\FR\FM\31JAN1.SGM
31JAN1
4891
Federal Register / Vol. 87, No. 20 / Monday, January 31, 2022 / Notices
(3) Women who care for a young child
(children ages 12 and younger; English
speaking),
(4) Women who care for a young child
(children ages 12 and younger; Spanish
speaking),
(5) Women who care for an aging
parent 65+ (English speaking),
(6) Women who care for an aging
parent 65+ (Spanish speaking),
(7) Men aged 65+ with one or more
chronic conditions (English speaking),
and
(8) Healthy adults 65+ (English
speaking).
This program evaluation will assist
CDC in determining if the media
campaign, along with partner outreach,
was successful in changing awareness,
knowledge, and behaviors of consumers
and HCPs in select target markets. The
data collected will also be used to
inform future refinement and
implementation of the campaign
(materials and tactics).
CDC requests OMB approval for an
estimated 68 annual burden hours.
There are no costs to respondents other
than their time.
HCP audiences include:
(1) Emergency Medical Services
personnel (English speaking),
(2) Nurse Practitioners and Physician
Assistants who work at urgent care
clinics (English speaking),
(3) Emergency Department triage
nurses (English speaking),
(4) General medical ward staff
(English speaking),
(5) Primary care physicians (English
speaking),
(6) Long-term care (LTC) nurses
(English speaking), and
(7) LTC medical technicians and
sitters (English speaking).
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden
per
response
(in hours)
Number of
responses
per
respondent
Total burden
(in hours)
Type of respondents
Form name
Consumer ..............................
Consumer ..............................
HCPs .....................................
Get Ahead of Sepsis Consumer Pre-test ....
Get Ahead of Sepsis Consumer Post-test ...
Get Ahead of Sepsis HCP Campaign Pretest.
Get Ahead of Sepsis HCP Campaign Posttest.
50
50
50
1
1
1
20/60
20/60
20/60
17
17
17
50
1
20/60
17
.......................................................................
........................
........................
........................
68
HCPs .....................................
Total ...............................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–01885 Filed 1–28–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[60Day–22–0978; Docket No. CDC–2022–
0012]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
SUMMARY:
VerDate Sep<11>2014
17:38 Jan 28, 2022
Jkt 256001
proposed information collection project
titled Emerging Infections Program
(EIP). EIP is a population-based
surveillance system designed to collect
information via active, laboratory case
finding that is used for detecting,
identifying, and monitoring emerging
pathogens.
CDC must receive written
comments on or before April 1, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0012 by either of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
DATES:
Centers for Disease Control and
Prevention
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
E:\FR\FM\31JAN1.SGM
31JAN1
]]>Agencies
[Federal Register Volume 87, Number 20 (Monday, January 31, 2022)]
[Notices]
[Pages 4890-4891]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01885]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-22CB; Docket No. CDC-2022-0011]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal Agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Assessment for the Get Ahead of
Sepsis (GAOS) Consumer Campaign. This assessment collects on-line
survey data from target consumer groups and healthcare professionals
(HCP) before and after the campaign.
DATES: CDC must receive written comments on or before April 1, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0011 by either of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal Agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Assessment for the Get Ahead of Sepsis (GAOS) Consumer Campaign--
New--National Center for Emerging and Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Sepsis is a life threating emergency, and it is the body's
overactive and toxic response to an infection. Each year 1.7 million
adults in the United States develop sepsis, with 270,000 fatalities.
Sepsis is the leading cause of death in hospitals and one out of three
hospital fatalities are due to sepsis infection. Sepsis management in
U.S. hospitals is the highest when compared to inpatient cost for all
other medical conditions. Annual costs are estimated to be over $62
billion.
In media and public health campaigns, antimicrobial resistance and
sepsis are rarely presented together which does not make their linkage
apparent. It has been concluded that sepsis and antimicrobial
stewardship should not be discussed in isolation. Surprisingly, 24
percent of adults in the U.S. have never heard of sepsis, so this
presents a unique opportunity for future messaging campaigns.
The goals of the GAOS educational campaign are to prevent and
reduce infections that lead to sepsis and to optimize healthcare
quality and patient safety by raising awareness, knowledge, and
motivating behavior change related to sepsis prevention, early
recognition, and appropriate treatment among consumer target audiences.
A panel survey will be utilized to recruit participants. Surveys will
be distributed to consumer target groups and HCPs both before and after
the media campaign and partner outreach.
Consumer audiences include:
(1) Cancer patients and their caregivers (English speaking),
(2) Patients who survived severe COVID-19 or sepsis and their
caregivers (English speaking),
[[Page 4891]]
(3) Women who care for a young child (children ages 12 and younger;
English speaking),
(4) Women who care for a young child (children ages 12 and younger;
Spanish speaking),
(5) Women who care for an aging parent 65+ (English speaking),
(6) Women who care for an aging parent 65+ (Spanish speaking),
(7) Men aged 65+ with one or more chronic conditions (English
speaking), and
(8) Healthy adults 65+ (English speaking).
HCP audiences include:
(1) Emergency Medical Services personnel (English speaking),
(2) Nurse Practitioners and Physician Assistants who work at urgent
care clinics (English speaking),
(3) Emergency Department triage nurses (English speaking),
(4) General medical ward staff (English speaking),
(5) Primary care physicians (English speaking),
(6) Long-term care (LTC) nurses (English speaking), and
(7) LTC medical technicians and sitters (English speaking).
This program evaluation will assist CDC in determining if the media
campaign, along with partner outreach, was successful in changing
awareness, knowledge, and behaviors of consumers and HCPs in select
target markets. The data collected will also be used to inform future
refinement and implementation of the campaign (materials and tactics).
CDC requests OMB approval for an estimated 68 annual burden hours.
There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Consumer...................... Get Ahead of 50 1 20/60 17
Sepsis Consumer
Pre-test.
Consumer...................... Get Ahead of 50 1 20/60 17
Sepsis Consumer
Post-test.
HCPs.......................... Get Ahead of 50 1 20/60 17
Sepsis HCP
Campaign Pre-
test.
HCPs.......................... Get Ahead of 50 1 20/60 17
Sepsis HCP
Campaign Post-
test.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 68
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-01885 Filed 1-28-22; 8:45 am]
BILLING CODE 4163-18-P
